ERBB2 and breast cancer: Considering that KLRB1 expression correlates with the molecular typing of breast cancer, we further analyzed and found that KLRB1 was also associated with the prognosis of Luminal A and Luminal B subtypes, but not statistically significant with HER-2 positivity and TNBC survival (Figures S1A–D).